Potential pharmaceutical agents sold as doping productsResearchers from the German Sport University Cologne in Germany have disclosed that non-steroidal and tissue-selective anabolic agents such as Selective Androgen Receptor Modulators (SARMs) are prompting a demand high due to their performance enhancement qualities.

The study highlights that the misuse of therapeutics by athletes, without clinical approval, cannot be dismissed, as per Mario Thevis, Ph.D.

Selective Androgen Receptor Modulators (SARMs) represents a class of therapeutics meant to treat health complications such as benign prostatic hyperplasia (BPH), sarcopenia, osteoporosis, and cancer cachexia. They are gaining popularity in the world of professional sport doping community because they offer advantages of traditional anabolic/androgenic steroids such as testosterone with fewer unwanted side effects.